Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 5Skin Diseases 1Precancerous Conditions 1Keratosis 1Hutchinson's Melanotic Freckle 1Carcinoma, Basal Cell 1

Interventions

HhAntag691 18Imiquimod 10sonidegib 8Photochemotherapy 71-phenyl-3,3-dimethyltriazene 6methyl 5-aminolevulinate 4Surgical Procedures, Operative 4Biopsy 4Aminolevulinic Acid 4cemiplimab 3Mohs Surgery 3Microscopy, Confocal 3Itraconazole 3IPI-926 33-ingenyl angelate 3tazarotene 2Microarray Analysis 2Laser Therapy 2Gene Expression Profiling 2Eflornithine 2Drug Evaluation 2Acitretin 2tozuleristide 1teriflunomide 1talimogene laherparepvec 1silmitasertib 1remetinostat 1pembrolizumab 1gusacitinib 1green tea extract polyphenone E 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Basal Cell × BF-200 ALA × Clear all
NCT02144077 2022-11-03

Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy

Biofrontera Bioscience GmbH

Phase 3 Completed
281 enrolled 16 charts
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡